Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs
March 07, 2023 08:00 ET
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative...
ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023 08:00 ET
|
ReWalk Robotics Ltd.
Strong Conclusion to 2022 – Q4’22 Revenue Highest Since Start of COVID-19 Pandemic Record Quarterly MyoCycle Sales Supplement Improved Exoskeleton Revenue MARLBOROUGH, Mass. and BERLIN and...
ReWalk Robotics to Report Fourth Quarter and Fiscal Year-End 2022 Financial Results on February 23, 2023
February 16, 2023 08:00 ET
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will...
“Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp
January 05, 2023 08:30 ET
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass., BERLIN, and YOKNEAM, Israel, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for...
ReWalk Announces Extension of Share Repurchase Program
December 22, 2022 08:00 ET
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Dec. 22, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical...
Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation
November 11, 2022 08:00 ET
|
ReWalk Robotics Ltd.
Precedent set for all future cases as State Court verdict is legally binding and enforceable Following the outcome of this legal dispute, eligible paraplegics in Germany have an easier pathway to be...
ReWalk Robotics Reports Third Quarter 2022 Financial Results
November 07, 2022 08:00 ET
|
ReWalk Robotics Ltd.
ReWalk Has Submitted the First Case to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries As of November 4th, ReWalk Has...
ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022
October 31, 2022 16:15 ET
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will...
ReWalk Takes Another Step Toward Medicare Coverage
September 28, 2022 07:15 ET
|
ReWalk Robotics Ltd.
ReWalk to submit first cases for Medicare coverage through Medicare Administrative Contractors (MACs)Centers for Medicare and Medicaid Services (CMS) affirms that the MACs have discretion to cover and...
German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals
September 12, 2022 08:00 ET
|
ReWalk Robotics Ltd.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical...